US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 13.050
  • +0.250+1.95%
Trading May 2 11:33 ET
647.69MMarket Cap-7465P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
114.85%236.57M
114.85%236.57M
109.80%253.76M
--261.1M
--270.64M
937.60%110.11M
937.60%110.11M
--120.95M
653.16%10.61M
--10.61M
-Cash and cash equivalents
-43.78%49.3M
-43.78%49.3M
76.28%86.3M
--101.14M
--138.25M
726.43%87.7M
726.43%87.7M
--48.96M
653.16%10.61M
--10.61M
-Short-term investments
735.66%187.26M
735.66%187.26M
132.59%167.46M
--159.96M
--132.39M
--22.41M
--22.41M
--72M
--0
--0
Other current assets
364.12%12.54M
364.12%12.54M
1,144.80%11.61M
--8.39M
--4.64M
429.61%2.7M
429.61%2.7M
--933K
794.74%510K
--510K
Total current assets
120.81%249.1M
120.81%249.1M
117.72%265.38M
--269.49M
--275.27M
914.30%112.81M
914.30%112.81M
--121.89M
658.66%11.12M
--11.12M
Non current assets
Investments and advances
--2.48M
--2.48M
--12.13M
--21.68M
--31.12M
--0
--0
----
----
----
Non current deferred assets
-96.87%51K
-96.87%51K
--0
--0
--0
54,266.67%1.63M
54,266.67%1.63M
--564K
-85.00%3K
--3K
Other non current assets
----
----
--51K
--51K
--39K
----
----
----
----
----
Total non current assets
55.30%2.53M
55.30%2.53M
2,059.57%12.18M
--21.73M
--31.16M
54,266.67%1.63M
54,266.67%1.63M
--564K
-85.00%3K
--3K
Total assets
119.88%251.64M
119.88%251.64M
126.67%277.56M
--291.22M
--306.44M
928.69%114.44M
928.69%114.44M
--122.45M
648.65%11.13M
--11.13M
Liabilities
Current liabilities
Payables
-68.48%601K
-68.48%601K
117.44%5.57M
--2.2M
--2.39M
149.93%1.91M
149.93%1.91M
--2.56M
44.23%763K
--763K
-accounts payable
-68.48%601K
-68.48%601K
117.44%5.57M
--2.2M
--2.39M
149.93%1.91M
149.93%1.91M
--2.56M
44.23%763K
--763K
Current accrued expenses
60.41%9.88M
60.41%9.88M
71.14%7.97M
--4.01M
--8.17M
43.56%6.16M
43.56%6.16M
--4.66M
7,846.30%4.29M
--4.29M
Current liabilities
29.94%10.48M
29.94%10.48M
87.58%13.54M
--6.21M
--10.56M
59.62%8.07M
59.62%8.07M
--7.22M
-0.57%5.05M
--5.05M
Non current liabilities
Preferred securities outside stock equity
--0
--0
--0
--0
--0
447.12%158.64M
447.12%158.64M
--158.64M
--29M
--29M
Total non current liabilities
--0
--0
--0
--0
--0
447.12%158.64M
447.12%158.64M
--158.64M
--29M
--29M
Total liabilities
-93.71%10.48M
-93.71%10.48M
-91.83%13.54M
--6.21M
--10.56M
389.61%166.71M
389.61%166.71M
--165.86M
569.88%34.05M
--34.05M
Shareholders'equity
Share capital
300.00%4K
300.00%4K
300.00%4K
--4K
--4K
0.00%1K
0.00%1K
--1K
0.00%1K
--1K
-common stock
300.00%4K
300.00%4K
300.00%4K
--4K
--4K
0.00%1K
0.00%1K
--1K
0.00%1K
--1K
Retained earnings
-136.14%-124.71M
-136.14%-124.71M
-129.37%-100.32M
---77.56M
---65.42M
-129.50%-52.81M
-129.50%-52.81M
---43.74M
-538.66%-23.01M
---23.01M
Paid-in capital
67,651.48%365.86M
67,651.48%365.86M
113,045.03%364.33M
--362.57M
--361.29M
535.29%540K
535.29%540K
--322K
1,600.00%85K
--85K
Total stockholders'equity
561.37%241.15M
561.37%241.15M
708.13%264.01M
--285.01M
--295.88M
-128.00%-52.27M
-128.00%-52.27M
---43.41M
-537.34%-22.93M
---22.93M
Total equity
561.37%241.15M
561.37%241.15M
708.13%264.01M
--285.01M
--295.88M
-128.00%-52.27M
-128.00%-52.27M
---43.41M
-537.34%-22.93M
---22.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments 114.85%236.57M114.85%236.57M109.80%253.76M--261.1M--270.64M937.60%110.11M937.60%110.11M--120.95M653.16%10.61M--10.61M
-Cash and cash equivalents -43.78%49.3M-43.78%49.3M76.28%86.3M--101.14M--138.25M726.43%87.7M726.43%87.7M--48.96M653.16%10.61M--10.61M
-Short-term investments 735.66%187.26M735.66%187.26M132.59%167.46M--159.96M--132.39M--22.41M--22.41M--72M--0--0
Other current assets 364.12%12.54M364.12%12.54M1,144.80%11.61M--8.39M--4.64M429.61%2.7M429.61%2.7M--933K794.74%510K--510K
Total current assets 120.81%249.1M120.81%249.1M117.72%265.38M--269.49M--275.27M914.30%112.81M914.30%112.81M--121.89M658.66%11.12M--11.12M
Non current assets
Investments and advances --2.48M--2.48M--12.13M--21.68M--31.12M--0--0------------
Non current deferred assets -96.87%51K-96.87%51K--0--0--054,266.67%1.63M54,266.67%1.63M--564K-85.00%3K--3K
Other non current assets ----------51K--51K--39K--------------------
Total non current assets 55.30%2.53M55.30%2.53M2,059.57%12.18M--21.73M--31.16M54,266.67%1.63M54,266.67%1.63M--564K-85.00%3K--3K
Total assets 119.88%251.64M119.88%251.64M126.67%277.56M--291.22M--306.44M928.69%114.44M928.69%114.44M--122.45M648.65%11.13M--11.13M
Liabilities
Current liabilities
Payables -68.48%601K-68.48%601K117.44%5.57M--2.2M--2.39M149.93%1.91M149.93%1.91M--2.56M44.23%763K--763K
-accounts payable -68.48%601K-68.48%601K117.44%5.57M--2.2M--2.39M149.93%1.91M149.93%1.91M--2.56M44.23%763K--763K
Current accrued expenses 60.41%9.88M60.41%9.88M71.14%7.97M--4.01M--8.17M43.56%6.16M43.56%6.16M--4.66M7,846.30%4.29M--4.29M
Current liabilities 29.94%10.48M29.94%10.48M87.58%13.54M--6.21M--10.56M59.62%8.07M59.62%8.07M--7.22M-0.57%5.05M--5.05M
Non current liabilities
Preferred securities outside stock equity --0--0--0--0--0447.12%158.64M447.12%158.64M--158.64M--29M--29M
Total non current liabilities --0--0--0--0--0447.12%158.64M447.12%158.64M--158.64M--29M--29M
Total liabilities -93.71%10.48M-93.71%10.48M-91.83%13.54M--6.21M--10.56M389.61%166.71M389.61%166.71M--165.86M569.88%34.05M--34.05M
Shareholders'equity
Share capital 300.00%4K300.00%4K300.00%4K--4K--4K0.00%1K0.00%1K--1K0.00%1K--1K
-common stock 300.00%4K300.00%4K300.00%4K--4K--4K0.00%1K0.00%1K--1K0.00%1K--1K
Retained earnings -136.14%-124.71M-136.14%-124.71M-129.37%-100.32M---77.56M---65.42M-129.50%-52.81M-129.50%-52.81M---43.74M-538.66%-23.01M---23.01M
Paid-in capital 67,651.48%365.86M67,651.48%365.86M113,045.03%364.33M--362.57M--361.29M535.29%540K535.29%540K--322K1,600.00%85K--85K
Total stockholders'equity 561.37%241.15M561.37%241.15M708.13%264.01M--285.01M--295.88M-128.00%-52.27M-128.00%-52.27M---43.41M-537.34%-22.93M---22.93M
Total equity 561.37%241.15M561.37%241.15M708.13%264.01M--285.01M--295.88M-128.00%-52.27M-128.00%-52.27M---43.41M-537.34%-22.93M---22.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg